362 results
Keyword clopidogrel Remove keyword
-
List item
Human medicine European public assessment report (EPAR): Clopidogrel/Acetylsalicylic acid Teva
clopidogrel, acetylsalicylic acid, Acute Coronary Syndrome; Myocardial Infarction
Date of authorisation: 01/09/2014, Revision: 1, Withdrawn, Last updated: 28/04/2017Clopidogrel/Acetylsalicylic acid Teva Acute Coronary … Withdrawn clopidogrelacetylsalicylic acid Overview The marketing … marketing authorisation for Clopidogrel/Acetylsalicylic acid Teva has been withdrawn … -
List item
Human medicine European public assessment report (EPAR): Clopidogrel Zentiva (previously Clopidogrel Winthrop) (updated)
clopidogrel, Stroke; Peripheral Vascular Diseases; Myocardial Infarction; Acute Coronary Syndrome
Date of authorisation: 15/07/2008, Revision: 31, Authorised, Last updated: 23/06/2022Clopidogrel Zentiva (previously Clopidogrel Winthrop) Cardiovascular … Authorised clopidogrel Overview This is a summary … assessment report (EPAR) for Clopidogrel Zentiva. It explains how … -
List item
Human medicine European public assessment report (EPAR): Clopidogrel Viatris (previously Clopidogrel Taw Pharma)
clopidogrel besilate, Peripheral Vascular Diseases; Stroke; Myocardial Infarction
Date of authorisation: 16/10/2009,
, Revision: 25, Authorised, Last updated: 14/03/2022
Clopidogrel Viatris (previously Clopidogrel Taw Pharma) Vascular Diseases Cardiovascular … Clopidogrel Viatris (previously Clopidogrel Taw Pharma … EMA/909073/2011 EMEA/H/C/001189 Clopidogrel Viatris1 clopidogrel) An overview of Clopidogrel Viatris and why it is authorised … -
List item
Human medicine European public assessment report (EPAR): Clopidogrel Taw Pharma (previously Clopidogrel Mylan)
clopidogrel hydrochloride, Peripheral Vascular Diseases; Stroke; Myocardial Infarction; Acute Coronary Syndrome
Date of authorisation: 21/09/2009,, Revision: 19, Authorised, Last updated: 22/02/2022
Clopidogrel Taw Pharma (previously Clopidogrel Mylan) Vascular Diseases Cardiovascular … Authorised clopidogrel Overview Clopidogrel Taw Pharma is a medicine … infarction (heart attack). Clopidogrel Taw Pharma can be started … -
List item
Human medicine European public assessment report (EPAR): Clopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover)
clopidogrel, acetylsalicylic acid, Acute Coronary Syndrome; Myocardial Infarction
Date of authorisation: 14/03/2010, Revision: 22, Authorised, Last updated: 13/11/2019Clopidogrel/Acetylsalicylic acid Zentiva (previously … Authorised clopidogrelacetylsalicylic acid Overview This document … Assessment Report (EPAR) for Clopidogrel/Acetylsalicylic acid Zentiva. It explains … -
List item
Human medicine European public assessment report (EPAR): Clopidogrel Teva Pharma (previously Clopidogrel HCS)
clopidogrel (as hydrochloride), Myocardial Infarction; Peripheral Vascular Diseases; Stroke
Date of authorisation: 21/09/2009,, Revision: 9, Withdrawn, Last updated: 24/10/2017
Clopidogrel Teva Pharma (previously Clopidogrel HCS) Myocardial Infarction Peripheral … Withdrawn clopidogrel Overview The marketing authorisation … marketing authorisation for Clopidogrel Teva Pharma has been withdrawn … -
List item
Human medicine European public assessment report (EPAR): Clopidogrel Acino
clopidogrel, Peripheral Vascular Diseases; Acute Coronary Syndrome; Myocardial Infarction; Stroke
Date of authorisation: 28/07/2009,, Revision: 6, Withdrawn, Last updated: 04/01/2018
Clopidogrel Acino Peripheral Vascular … Withdrawn clopidogrel Overview The marketing authorisation … marketing authorisation for Clopidogrel Acino has been withdrawn … -
List item
Human medicine European public assessment report (EPAR): Clopidogrel ratiopharm
clopidogrel, Peripheral Vascular Diseases; Stroke; Myocardial Infarction
Date of authorisation: 23/09/2009,, Revision: 5, Withdrawn, Last updated: 12/12/2013
Clopidogrel ratiopharm Peripheral Vascular … Withdrawn clopidogrel Overview The marketing authorisation … marketing authorisation for Clopidogrel ratiopharm has been withdrawn … -
List item
Human medicine European public assessment report (EPAR): Clopidogrel Sandoz
clopidogrel, Peripheral Vascular Diseases; Stroke; Myocardial Infarction
Date of authorisation: 21/09/2009,, Revision: 2, Withdrawn, Last updated: 26/10/2011
Clopidogrel Sandoz Peripheral Vascular … Withdrawn clopidogrel Overview The marketing authorisation … marketing authorisation for Clopidogrel Sandoz has been withdrawn … -
List item
Human medicine European public assessment report (EPAR): Clopidogrel Hexal
clopidogrel, Peripheral Vascular Diseases; Acute Coronary Syndrome; Myocardial Infarction; Stroke
Date of authorisation: 28/07/2009,, Revision: 2, Withdrawn, Last updated: 26/07/2012
Clopidogrel Hexal Peripheral Vascular … Withdrawn clopidogrel Overview The marketing authorisation … marketing authorisation for Clopidogrel Hexal has been withdrawn … -
List item
Human medicine European public assessment report (EPAR): Clopidogrel ratiopharm GmbH
clopidogrel, Peripheral Vascular Diseases; Acute Coronary Syndrome; Myocardial Infarction; Stroke
Date of authorisation: 28/07/2009,, Revision: 12, Withdrawn, Last updated: 25/01/2021
Clopidogrel ratiopharm GmbH Peripheral … Withdrawn clopidogrel Overview The marketing authorisation … marketing authorisation for Clopidogrel Ratiopharm GmbH has been … -
List item
Human medicine European public assessment report (EPAR): Clopidogrel 1A Pharma
clopidogrel, Peripheral Vascular Diseases
Date of authorisation: 28/07/2009,, Revision: 1, Withdrawn, Last updated: 28/02/2011
Clopidogrel 1A Pharma Peripheral Vascular … Withdrawn clopidogrel Overview The marketing authorisation … marketing authorisation for Clopidogrel 1A Pharma has been withdrawn … -
List item
Human medicine European public assessment report (EPAR): Clopidogrel Acino Pharma
clopidogrel, Peripheral Vascular Diseases; Stroke; Myocardial Infarction
Date of authorisation: 21/09/2009,, Revision: 1, Withdrawn, Last updated: 26/07/2012
Clopidogrel Acino Pharma Peripheral … Withdrawn clopidogrel Overview The marketing authorisation … marketing authorisation for Clopidogrel Acino Pharma has been withdrawn … -
List item
Human medicine European public assessment report (EPAR): Clopidogrel Krka (updated)
clopidogrel (as hydrochloride), Peripheral Vascular Diseases; Stroke; Myocardial Infarction
Date of authorisation: 23/09/2009,, Revision: 18, Authorised, Last updated: 10/06/2022
Clopidogrel Krka Vascular Diseases Cardiovascular … Authorised clopidogrel Overview This is a summary … assessment report (EPAR) for Clopidogrel Krka. It explains how the … -
List item
Human medicine European public assessment report (EPAR): Clopidogrel ratiopharm (updated)
clopidogrel (as hydrogen sulfate), Myocardial Infarction; Acute Coronary Syndrome; Peripheral Vascular Diseases; Stroke
Date of authorisation: 18/02/2015,, Revision: 13, Authorised, Last updated: 07/06/2022
Clopidogrel ratiopharm Cardiovascular … Authorised clopidogrel Overview This is a summary … assessment report (EPAR) for Clopidogrel ratiopharm. It explains how … -
List item
Human medicine European public assessment report (EPAR): Clopidogrel TAD
clopidogrel (as hydrochloride), Peripheral Vascular Diseases; Stroke; Myocardial Infarction
Date of authorisation: 23/09/2009,, Revision: 14, Authorised, Last updated: 23/11/2021
Clopidogrel TAD Nervous System Diseases Central … Clopidogrel TAD … INN, clopidogrel 30 Churchill Place … -
List item
Human medicine European public assessment report (EPAR): Clopidogrel DURA
clopidogrel (as hydrochloride), Peripheral Vascular Diseases; Stroke; Myocardial Infarction
Date of authorisation: 21/07/2009,, Revision: 6, Withdrawn, Last updated: 10/07/2015
Clopidogrel DURA Peripheral Vascular … Withdrawn clopidogrel Overview The marketing authorisation … marketing authorisation for Clopidogrel Dura has been withdrawn at … -
List item
Human medicine European public assessment report (EPAR): Clopidogrel Qualimed
clopidogrel (as hydrochloride), Peripheral Vascular Diseases; Stroke; Myocardial Infarction
Date of authorisation: 23/09/2009,, Revision: 4, Withdrawn, Last updated: 08/09/2014
Clopidogrel Qualimed Peripheral Vascular … Withdrawn clopidogrel Overview The marketing authorisation … marketing authorisation for Clopidogrel Qualimed has been withdrawn … -
List item
Human medicine European public assessment report (EPAR): Clopidogrel HCS
clopidogrel (as hydrochloride), Peripheral Vascular Diseases; Acute Coronary Syndrome; Myocardial Infarction; Stroke
Date of authorisation: 28/10/2010,, Revision: 8, Authorised, Last updated: 01/08/2018
Clopidogrel HCS Vascular Diseases Cardiovascular … Authorised clopidogrel Overview This is a summary … assessment report (EPAR) for Clopidogrel HCS. It explains how the … -
List item
Human medicine European public assessment report (EPAR): Clopidogrel Acino Pharma GmbH
clopidogrel, Peripheral Vascular Diseases; Stroke; Myocardial Infarction
Date of authorisation: 21/09/2009,, Revision: 1, Withdrawn, Last updated: 26/07/2012
Clopidogrel Acino Pharma GmbH Peripheral … Withdrawn clopidogrel Overview The marketing authorisation … marketing authorisation for Clopidogrel Acino Pharma GmbH has been … -
List item
Withdrawn application: Clopidogrel Teva Pharma
clopidogrel, date of withdrawal: 22/04/2009, Initial authorisation, Last updated: 23/04/2009Clopidogrel Teva Pharma: Withdrawn applic … Clopidogrel Teva Pharma: Withdrawal of … authorisation application for Clopidogrel Teva Pharma clopidogrel On 22 April 2009, Teva … -
List item
Human medicine European public assessment report (EPAR): Clopidogrel BMS
clopidogrel (as hydrogen sulfate), Stroke; Peripheral Vascular Diseases; Myocardial Infarction; Acute Coronary Syndrome
Date of authorisation: 16/07/2008, Revision: 3, Withdrawn, Last updated: 26/01/2010Clopidogrel BMS Stroke Peripheral Vascular … Clopidogrel BMS … Microsoft Word - Clopidogrel BMS Public Statement.doc … -
List item
Opinion/decision on a Paediatric investigation plan (PIP): Clopidogrel Zentiva (previously Clopidogrel Winthrop), clopidogrel
Decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Therapeutic area: Cardiovascular diseases
PIP number: Clopidogrel, Route(s) of administration: Oral use, Pharmaceutical form(s): Age-appropriate oral formulation, Film-coated tablet
Decision date: 22/09/2009, Last updated: 07/12/2009, Compliance check: XClopidogrel Cardiovascular diseases … Clopidogrel … Word - Decision and Opinion Clopidogrel Winthrop 000617-PIP01-09 … -
List item
Human medicine European public assessment report (EPAR): Clopidogrel Krka d.d. (previously Zopya) (updated)
clopidogrel (as hydrochloride), Peripheral Vascular Diseases; Stroke; Myocardial Infarction
Date of authorisation: 20/09/2009,, Revision: 14, Authorised, Last updated: 10/06/2022
Clopidogrel Krka d.d. (previously Zopya) Vascular … Authorised clopidogrel Overview This is a summary … assessment report (EPAR) for Clopidogrel Krka d.d. It explains how … -
List item
Human medicine European public assessment report (EPAR): Clopidogrel Teva (hydrogen sulphate) (updated)
clopidogrel (as hydrogen sulfate), Acute Coronary Syndrome; Peripheral Vascular Diseases; Myocardial Infarction; Stroke
Date of authorisation: 27/07/2009,, Revision: 18, Authorised, Last updated: 10/06/2022
Clopidogrel Teva (hydrogen sulphate) Cardiovascular … Clopidogrel Teva (hydrogen sulphate … EMEA/356088/2009 EMEA/H/C/1053 Clopidogrel Teva clopidogrel EPAR summary for the …